SynBioBeta
SynBioBeta is a private events and media company that runs the annual Global Synthetic Biology Conference in San Jose, supplemented by a newsletter, podcast, video library, and digital summits, serving synthetic biology founders, biotech investors, biopharma companies, and researchers.
- Company typePrivate
- Founded2012
- HeadquartersPleasant Hill, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What SynBioBeta does
SynBioBeta is a privately-held events and media company founded in 2012, operating from Lafayette, California. The company runs an annual flagship conference at the San Jose Convention Center (SynBioBeta 2026 ran May 4-7, 2026; SynBioBeta 2027 is scheduled May 3-6, 2027) that brings together synthetic biology founders, biotech and biopharma investors, and industry executives, supplemented by digital summits (e.g., the Programmable Biology Digital Summit in December 2025), a weekly newsletter, The Inside Track podcast hosted by Director of Content Jeff Buguliskis, an on-demand video library, and editorial coverage across categories including AIxBIO, biomanufacturing, bioeconomy policy, capital markets, and engineered human therapies.
The platform's underlying infrastructure is a content marketing and community-convening stack built on a website and digital media channels (newsletter, podcast, video), with distribution into owned social channels. SynBioBeta does not appear to develop proprietary software, APIs, or AI models; the technical footprint is the events platform and media CMS supporting articles, podcasts, videos, and registration flows.
The business model is event-driven and sponsorship-supported. The company generates revenue through tiered conference ticket sales (including Super Early Bird discounted passes), booth and event sponsorship, and sponsored content advertising on the website and across digital channels. Customer segments include synthetic biology startups and founders (primary), biotech investors and VCs (primary), synthetic biology researchers and scientists, and biopharma/life sciences companies seeking sponsorship, talent recruitment, and business development. The April 2025 GridX partnership extends the platform internationally with a multi-city roadshow for Latin American biotech startups. John Cumbers is Founder, with Jeff Buguliskis as Director of Content; headcount is reported at 1-10.
SynBioBeta firmographics
Firmographics- Name
- SynBioBeta
- Legal name
- SynBioBeta
- Website
- https://synbiobeta.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- SynBioBeta is a private events and media company that runs the annual Global Synthetic Biology Conference in San Jose, supplemented by a newsletter, podcast, video library, and digital summits, serving synthetic biology founders, biotech investors, biopharma companies, and researchers.
- Ownership category
- akta.pro rank
SynBioBeta industry classification
Industry- Product category
- Biotech Industry Events and Media
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Membership Organizations (8600)
- akta.pro primary industry
- Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)
Keywords
Where SynBioBeta is headquartered
LocationHeadquarters
- HQ city
- Pleasant Hill
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
SynBioBeta business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Conference Registration and Event Tickets: SynBioBeta generates revenue through ticket sales for its annual synthetic biology conferences, with tiered pricing including Super Early Bird passes and standard registration options. The events feature startup pitches, investor presentations, and industry networking.
- Advertising and Sponsorship: The platform generates revenue through sponsored content placements and advertising opportunities on its website and during events. Companies can sponsor presentations and purchase booth space at conferences.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Super Early Bird Pass - discounted conference registration |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
SynBioBeta product offering
Product offeringCore offering
SynBioBeta operates as an events and media company serving the synthetic biology industry. Its core offering is the annual SynBioBeta Conference held in San Jose, California, complemented by a digital content platform featuring a newsletter, podcast (The Inside Track), video content library, and editorial coverage of synthetic biology innovations, AIxbio developments, biomanufacturing, and policy.
Product overview
SynBioBeta is an events and media company operating a unified platform of conference events, content subscriptions, and multimedia channels serving the synthetic biology industry. The core offering is the annual SynBioBeta Conference supplemented by the SynBioBeta Newsletter for industry updates, The Inside Track Podcast featuring expert interviews, and a Video Content Library of event recordings. Together these products provide coverage of synthetic biology innovations, AI×bio developments, biomanufacturing, policy, and investment opportunities.
Differentiator
Problem solved
Functional benefit
Products and services
- SynBioBeta Conference Annual flagship synthetic biology conference bringing together innovators, investors, and industry leaders to discuss the future of biology and AI. Features presentations, networking, and startup showcases for the global synthetic biology community.
- SynBioBeta Newsletter Email newsletter providing updates on synthetic biology, AIxbio, biomanufacturing, policy insights, career opportunities, and exclusive member content for subscribers in the synthetic biology industry.
- The Inside Track Podcast Podcast series hosted by Jeff Buguliskis exploring topics spanning the world of synthetic biology, featuring conversations with leading innovators and thinkers in biodesign, sustainable materials, and AI in drug discovery.
- Video Content Library On-demand video library featuring recorded talks, presentations, and panel discussions from SynBioBeta events, including topics like AI in Bio, Biodesign, and Biomanufacturing.
- Industry News and Insights Editorial coverage of synthetic biology industry news, featuring articles on biotech innovations, funding announcements, and technology developments across categories including AIxBIO, Biomanufacturing, Bio Design, and more.
- Programmable Biology Digital Summit Digital summit event hosted by SynBioBeta covering programmable biology topics, providing an online complement to the annual in-person conference for the synthetic biology community.
Quantifiable outcome
- Events attract leading AIxBio founders, biopharma leaders, and investors
Companies that use SynBioBeta
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
SynBioBeta technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
SynBioBeta partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- GridXcoreGridX, Latin America's largest biotechnology investment fund and company builder, partnered with SynBioBeta as an industry leader supporting an international roadshow. The roadshow featured 21 innovative Latin American biotech startups connecting with North American investors across Tulsa (April 23), New York (April 29), and San Francisco (May 5). GridX has built a portfolio of 81 biotechnology startups from seven countries across Latin America, leveraging the region's biodiversity and talent pool.
Scale indicators3 records
Recent moves4 records
Expansion highlights4 records
SynBioBeta competitors and assessment
Company assessmentDirect peers
- Endpoints News: Endpoints News is a subscription-based biotech industry news outlet covering drug development, dealmaking, and biotech companies with a daily newsletter, breaking news, and live events. Highly comparable to SynBioBeta as a digitally native biotech media brand monetizing industry news and exclusive event coverage for a professional audience.
- BioSpace: BioSpace is a biotech industry news, jobs, and community platform serving life sciences professionals with editorial content, industry events, and a job board. Comparable to SynBioBeta in blending industry news, community features, and event-style audience engagement for biotech professionals.
- BioCentury: BioCentury provides biotech industry analysis, business intelligence, and hosts industry events and investor conferences. Comparable to SynBioBeta in combining subscription editorial content with curated industry events aimed at biotech executives, investors, and R&D leaders.
- Genetic Engineering & Biotechnology News (GEN): GEN is a long-running biotechnology publication covering biotech R&D, drug discovery, and bioprocessing with editorial content, webcasts, and industry events. Comparable to SynBioBeta as a vertically focused biotech media brand that combines editorial coverage with event-based audience engagement.
- Labiotech: Labiotech is a European digital media brand covering the biotech industry with a daily newsletter, editorial content, and industry events. Comparable to SynBioBeta as a niche digital biotech media brand using editorial plus events to serve a professional audience, with a regional rather than synthetic-biology vertical focus.
- FierceBiotech: FierceBiotech is part of the Fierce Network covering biotech industry news, R&D, and dealmaking with a daily newsletter and special reports. Comparable to SynBioBeta as a sector-focused digital biotech media brand monetizing audience attention through editorial and advertising to industry professionals.
- Bio-IT World: Bio-IT World covers the intersection of informatics, computing, and life sciences with editorial content, webcasts, and the Bio-IT World Conference & Expo. Comparable to SynBioBeta in the convergence of editorial and event-based coverage of a specialized biotech subcategory, with overlap at the AI-bio intersection.
Broad incumbents
- Biotechnology Innovation Organization (BIO): BIO is the largest trade association for the biotechnology industry and runs the BIO International Convention, the largest annual biotech event globally. Comparable to SynBioBeta as a membership-based industry body hosting flagship conferences and producing policy/industry content, but operating across all of biotechnology rather than focusing on the synthetic biology niche.
- STAT News: STAT News is a major health and life sciences news outlet covering biotech, pharma, and health policy with subscription newsletters and live events. Comparable to SynBioBeta as a high-quality biotech/health digital media brand with live events, but broader in scope and significantly larger in scale and reach.
Others
- Chemical & Engineering News (C&EN): C&EN is the news outlet of the American Chemical Society covering the chemical industry, including bio-based chemicals, biomanufacturing, and synthetic biology adjacencies. Comparable to SynBioBeta as a vertical industry media brand serving the chemistry/biotech intersection, but with a chemistry rather than synthetic biology focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
SynBioBeta social profiles
Digital presenceSynBioBeta financial estimates
Financial estimateRevenue estimate
Valuation estimate
SynBioBeta leadership team
Management profileNumber of profiles
Profiles2 records
SynBioBeta funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SynBioBeta M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SynBioBeta
What does SynBioBeta do?
SynBioBeta operates as an events and media company serving the synthetic biology industry. Its core offering is the annual SynBioBeta Conference held in San Jose, California, complemented by a digital content platform featuring a newsletter, podcast (The Inside Track), video content library, and editorial coverage of synthetic biology innovations, AIxbio developments, biomanufacturing, and policy.
Is SynBioBeta a public or private company?
SynBioBeta is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was SynBioBeta founded?
SynBioBeta was founded in 2012. It employs 11 to 50 people.
Where is SynBioBeta based?
SynBioBeta is headquartered in Pleasant Hill, United States, in the North America region.
How does SynBioBeta make money?
Two revenue lines are on record. Conference Registration and Event Tickets are the primary driver. The others are advertising and Sponsorship.
Who are SynBioBeta's main competitors?
Direct peers on record are Endpoints News, BioSpace, BioCentury, Genetic Engineering & Biotechnology News (GEN), Labiotech, FierceBiotech and Bio-IT World. Broad incumbents are Biotechnology Innovation Organization (BIO) and STAT News. Chemical & Engineering News (C&EN) is listed as an others.
Does SynBioBeta have an API?
No public API is recorded for SynBioBeta.
What industry is SynBioBeta in?
SynBioBeta's product category is Biotech Industry Events and Media. Its primary akta.pro industry code is HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms. Its NAICS code is 541714 and its SIC code is 8600.